The efficacy of neoadjuvant EGFR-TKI therapy combined with radical surgery for stage IIIB lung adenocarcinoma harboring EGFR mutations: A retrospective analysis based on single center.
Front Oncol
; 13: 1034897, 2023.
Article
in En
| MEDLINE
| ID: mdl-36776292
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Front Oncol
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Suiza